Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Glass

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Microbiology|July 6, 2000
Recombinant chimeric Borrelia proteins for diagnosis of Lyme diseaseM J Gomes-Solecki, J J Dunn, B J Luft, et al.
Lancet (London, England)|October 19, 1991
Epstein-Barr virus in AIDS-related primary central nervous system lymphomaE M MacMahon, J D Glass, S D Hayward, et al.
Neurology|June 20, 1998
Variable progression of HIV-associated dementiaF H Bouwman, R L Skolasky, D Hes, et al.
Annals of Neurology|December 1, 1991
Inter- and intra-examiner reliability of nerve conduction measurements in normal subjectsV Chaudhry, D R Cornblath, E D Mellits, et al.
Cell Death and Differentiation|April 29, 2006
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degenerationL Conforti, G Fang, B Beirowski, et al.
Journal of Medicinal Chemistry|January 19, 1996
Investigation of (Oxodioxolenyl)methyl carbamates as nonchiral bioreversible prodrug moieties for chiral aminesJ Alexander, D S Bindra, J D Glass, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 26, 2011
Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosisN Ticozzi, C Vance, A L Leclerc, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Microbiology|July 6, 2000
Recombinant chimeric Borrelia proteins for diagnosis of Lyme diseaseM J Gomes-Solecki, J J Dunn, B J Luft, et al.
Lancet (London, England)|October 19, 1991
Epstein-Barr virus in AIDS-related primary central nervous system lymphomaE M MacMahon, J D Glass, S D Hayward, et al.
Neurology|June 20, 1998
Variable progression of HIV-associated dementiaF H Bouwman, R L Skolasky, D Hes, et al.
Annals of Neurology|December 1, 1991
Inter- and intra-examiner reliability of nerve conduction measurements in normal subjectsV Chaudhry, D R Cornblath, E D Mellits, et al.
Cell Death and Differentiation|April 29, 2006
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degenerationL Conforti, G Fang, B Beirowski, et al.
Journal of Medicinal Chemistry|January 19, 1996
Investigation of (Oxodioxolenyl)methyl carbamates as nonchiral bioreversible prodrug moieties for chiral aminesJ Alexander, D S Bindra, J D Glass, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 26, 2011
Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosisN Ticozzi, C Vance, A L Leclerc, et al.
Journal of Medicinal Chemistry|November 8, 1996
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ H Hutchinson, J J Cook, K M Brashear, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Pageof 19